Cargando…

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting

The Malaria Policy Advisory Committee to the World Health Organization met in Geneva, Switzerland from 13 to 15 March, 2013. This article provides a summary of the discussions, conclusions and recommendations from that meeting. Meeting sessions included: a review of the efficacy of artemisinin-based...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702401/
https://www.ncbi.nlm.nih.gov/pubmed/23787092
http://dx.doi.org/10.1186/1475-2875-12-213
_version_ 1782275798542057472
collection PubMed
description The Malaria Policy Advisory Committee to the World Health Organization met in Geneva, Switzerland from 13 to 15 March, 2013. This article provides a summary of the discussions, conclusions and recommendations from that meeting. Meeting sessions included: a review of the efficacy of artemisinin-based combination therapy in Guyana and Suriname; the outcomes from a consultation on non-malaria febrile illness; the outcomes from the second meeting of the Evidence Review Group on malaria burden estimation; an update on the review of the WHO Guidelines for the Treatment of Malaria; an update regarding progress on the constitution of the vector control Technical Expert Group; updates on the RTS, S/AS01 vaccine and the malaria vaccine technology roadmap; financing and resource allocation for malaria control; malaria surveillance and the need for a surveillance, monitoring and evaluation Technical Expert Group; criteria and classification related to malaria elimination; the next meeting of the Evidence Review Group on Intermittent Preventive Treatment in pregnancy; an update on the soon-to-be launched Elimination Scenario Planning Tool; and an update on the process for the Global Technical Strategy for Malaria Control and Elimination (2016–2025). Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be formally issued and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.
format Online
Article
Text
id pubmed-3702401
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37024012013-07-06 Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting Malar J Meeting Report The Malaria Policy Advisory Committee to the World Health Organization met in Geneva, Switzerland from 13 to 15 March, 2013. This article provides a summary of the discussions, conclusions and recommendations from that meeting. Meeting sessions included: a review of the efficacy of artemisinin-based combination therapy in Guyana and Suriname; the outcomes from a consultation on non-malaria febrile illness; the outcomes from the second meeting of the Evidence Review Group on malaria burden estimation; an update on the review of the WHO Guidelines for the Treatment of Malaria; an update regarding progress on the constitution of the vector control Technical Expert Group; updates on the RTS, S/AS01 vaccine and the malaria vaccine technology roadmap; financing and resource allocation for malaria control; malaria surveillance and the need for a surveillance, monitoring and evaluation Technical Expert Group; criteria and classification related to malaria elimination; the next meeting of the Evidence Review Group on Intermittent Preventive Treatment in pregnancy; an update on the soon-to-be launched Elimination Scenario Planning Tool; and an update on the process for the Global Technical Strategy for Malaria Control and Elimination (2016–2025). Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be formally issued and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme. BioMed Central 2013-06-20 /pmc/articles/PMC3702401/ /pubmed/23787092 http://dx.doi.org/10.1186/1475-2875-12-213 Text en Copyright © 2013 Malaria Policy Advisory Committee and Secretariat; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Report
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
title Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
title_full Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
title_fullStr Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
title_full_unstemmed Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
title_short Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
title_sort malaria policy advisory committee to the who: conclusions and recommendations of march 2013 meeting
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702401/
https://www.ncbi.nlm.nih.gov/pubmed/23787092
http://dx.doi.org/10.1186/1475-2875-12-213